You just read:

Eisai Initiates Phase 2 Clinical Trial to Evaluate Lemborexant in the Treatment of Irregular Sleep-Wake Rhythm Disorder (ISWRD) in Dementia Patients

News provided by

Eisai Inc.

Oct 31, 2016, 08:10 ET